Alector's Series B Round

Alector raised a round of funding on March 10, 2014. Investors include Johnson & Johnson Innovation.

Alector is a neurology-focused startup that is focused on the discovery and development of immuno-modulatory therapies for Alzheimer's disease and other neurodegenerative disorders. The company is com…

Articles about Alector's Series B Round: